Skip to content

Addiction: all studies

Page 160 of 855: studies 1,591 to 1,600 of 8,547, newest first. Back to the addiction overview

Research

Kynurenine pathway profiles as markers of ketamine response in treatment-resistant depression.

Brain, Behavior, and Immunity July 5, 2026 Bruno Pedraz-Petrozzi, Marta Marszalek-Grabska, Emilia Fornal et al.

Treatment-resistant depression (TRD) remains a major clinical challenge, with highly variable responses to ketamine. Immune activation characterizes a subset of patients with TRD. The kynurenine pathway (KP), which integrates immunometabolic signals with glutamatergic neurotransmission, may provide candidate biomarkers to inform personalized treatment. We investigated whether KP metabolites and...

Turning Toward Mental Health - The Hinge Between Lived Experience and Developing the Keys for Growth

PhilPapers (PhilPapers Foundation) July 4, 2026 Jamison Johsnon preprint

The opening essay of the Turning Toward series sets out the method and the stakes of a philosophy of psychology grounded in testimony and in the analytical psychology of C. G. Jung. Moving from the etymology of agnosticism to Jung's 1959 "I know" and the letters in which he qualified it, the essay places the meditative encounter with the boundary between ego and Self within a long...

Stimulants, Psychoactive Plants, and Human Optimization: Medical Gatekeeping, Prohibition, and Adult Autonomy in Drug Policy

International Journal For Multidisciplinary Research July 4, 2026 Eric P. Rubenstein

Human societies have long used stimulant plants, psychoactive preparations, prescription medicines, commercial products, and traditional botanical substances to support wakefulness, endurance, labor, ritual, social participation, attention, motivation, fatigue resistance, performance, and human optimization. Modern drug policy regulates this field unevenly. Coffee, tea, caffeine, nicotine,...

DOI: 10.36948/ijfmr.2026.v08i04.82863 (opens in new tab) Full text (opens in new tab) Medical prescription Autonomy Principle of legality Cognition +6

The Combination of Oxytocin with Mindfulness-Based Group Therapy Reduces Negative Symptoms in Schizophrenia Spectrum Disorders: A Triple-Blind, Placebo-Controlled, Randomized, Controlled Clinical Pilot Trial (OXYMIND)

medRxiv July 4, 2026 Marco Zierhut, Max Alt, Inge Maria Hahne et al. preprint

Abstract Background Negative symptoms in schizophrenia spectrum disorders (SSD) remain insufficiently treated and require novel therapeutic approaches. Oxytocin may improve negative symptoms, although its effects appear highly context-dependent according to the social salience hypothesis. We conducted a randomized, triple-blind, placebo-controlled pilot study combining intranasal oxytocin with...

DOI: 10.64898/2026.07.01.26356996 (opens in new tab) Full text (opens in new tab) Oxytocin Blinding Placebo Schizophrenia object-oriented programming +8

High-order brain interactions during ketamine-induced state changes: A functional marker of response in late-life treatment-resistant depression?

Translational Psychiatry July 4, 2026 Krisha Shah, Rubén Herzog, Alan C. Swann et al.

Ketamine is a fast-acting intervention for treatment-resistant depression (TRD), yet only a subset of patients show robust clinical response, and the underlying neural mechanisms remain unclear. High-order interactions (HOI) derived from multivariate information theory provide a framework for examining nonlinear dependencies among brain regions beyond pairwise connectivity. One such metric, the...

Ligand-specific effects of 5-HT2A receptor antagonists on fear extinction in C57BL/6J mice: Comparative insights from MDL 11,939 and MDL 100,907

bioRxiv (Cold Spring Harbor Laboratory) July 3, 2026 Anastasia Tyulmenkova, Robert W. Stackman preprint

Abstract Serotonin (5-HT) 2A receptors (5-HT 2 AR) modulate corticolimbic circuits regulating fear extinction. Although activation of these receptors has been shown to facilitate fear extinction, the behavioral consequences of 5-HT 2 AR antagonism during extinction is not well defined. Here, we examined the systemic effects of two 5-HT 2 A receptor antagonists, the mixed 5-HT 2 A/ 2 C...

DOI: 10.64898/2026.06.29.735330 (opens in new tab) Full text (opens in new tab) Serotonin Extinction optical mineralogy Antagonism Receptor antagonist +4

DECOLONIZING THE ASSEMBLAGES OF CARE: THE VIBRANT MATERIALITY AND THERAPEUTIC GEOGRAPHIES OF TRADITIONAL PSYCHIATRY IN KASAR HAUSA, NORTHERN NIGERIA

July 3, 2026 Muazzim Safuwanu Ibrahim

Traditional mental healthcare frameworks across Kasar Hausa (Hausa land) remain a primary resource for individuals experiencing psychological distress. Despite this widespread reliance, Western clinical models frequently marginalize these practices as mere superstition. This conceptual review synthesizes anthropological literature and material culture studies to map out the internal logic,...

DOI: 10.14293/pr2199.004030.v1 (opens in new tab) Materiality auditing Indigenous Medical anthropology Kinship +16

Life and experience as irreducible dimensions of nature

Frontiers in Psychology July 3, 2026 Fredric Schiffer

Space and time are irreducible dimensions of nature—measurable but not derivable from anything more fundamental. Life and experience are here proposed as similarly irreducible dimensions. Together—sometimes referred to as lifeexperience to mark their inseparability—they constitute the dimensional ground from which emerges the Force of Experience—proposed as a candidate fifth fundamental force...

DOI: 10.3389/fpsyg.2026.1845620 (opens in new tab) Sophistication Consciousness Qualia Formalism music +14

Biochemical and Histopathological Evaluations of the Kidney and Liver in Ketamine-Induced Schizophrenic Model in Wistar Rats

Preprints.org July 3, 2026 Okwuchukwu Adachukwu Heavenah, Ugochukwu Samuel Aguwa, Ukoha Ukoha preprint

Background: Ketamine, a dissociative anesthetic, is widely used in experimental schizophrenia models due to its ability to mimic psychotic symptoms through N-methyl-D-aspartate (NMDA) receptor antagonism. Despite its utility, concerns remain regarding its potential systemic toxicity, particularly in the liver and kidneys. Method: This study investigated the dose- and time-dependent hepatotoxic...